Bacterial DNA and oligodeoxynucleotides containing cytosine^phosphate^guanosine sequences and thereby mimicking prokaryotic DNA, have recently been shown to exert potent immunostimulatory properties. As skin normally harbors bacteria, and as the bacterial content and the levels of bacterial degradation products increase during skin infection, we analyzed the potential in£ammatogenic role of bacterial DNA and oligodeoxynucleotides in a mouse model of cutaneous in£ammation. Bacterial DNA from Staphylococcus aureus was injected intradermally into mice and its in£amma-togenic properties were compared with synthetic phosphodiester and phosphorothioate cytosine^phosphateĝ uanosine-or GpC-containing oligodeoxynucleotides.
Bacterial DNA and oligodeoxynucleotides containing cytosine^phosphate^guanosine sequences and thereby mimicking prokaryotic DNA, have recently been shown to exert potent immunostimulatory properties. As skin normally harbors bacteria, and as the bacterial content and the levels of bacterial degradation products increase during skin infection, we analyzed the potential in£ammatogenic role of bacterial DNA and oligodeoxynucleotides in a mouse model of cutaneous in£ammation. Bacterial DNA from Staphylococcus aureus was injected intradermally into mice and its in£amma-togenic properties were compared with synthetic phosphodiester and phosphorothioate cytosine^phosphateĝ uanosine-or GpC-containing oligodeoxynucleotides.
A peak in£ammatory in¢ltrate in the skin was seen already 2 d after injection with either bacterial DNA or the phosphodiester cytosine^phosphate^guanosine-oligodeoxynucleotides. In contrast, nuclease-resistant phosphorothioate cytosine^phosphate^guanosine-induced dermatitis peaked 7 d after intradermal injection. The in£ammatory in¢ltrates consisted mainly of macrophages, and depletion of this cell population resulted in a signi¢cant (p ¼ 0.0001) decrease in the severity of in£ammation, which suggests that macrophages play a central part in in£ammatory responses in the skin following exposure to cytosine^phosphate^guano-sine-containing oligodeoxynucleotides. A signi¢cant decrease in local in£ammatory in¢ltrate was also seen in mice with de¢ciencies in neutrophil or lymphocyte populations, which indicates that these cell populations may also be involved in mediating in£ammatory signals after the injection of immunostimulatory DNA sequences. In summary, our results suggest that bacterial DNA is an important virulence determinant and in£ammatory stimulus during skin infections. Key words: bacterial DNA/mice/skin/synthetic oligodeoxynucleotides. J Invest Dermatol 121: 294^299, 2003 B acterial DNA is known to have stimulatory e¡ects (Tokunaga et al, 1984; Yamamoto et al, 1992) on several immune cell populations, in both humans and mice. This e¡ect has been shown to be largely dependent on cytosine^phosphate^guanosine (CpG) sequences (reviewed in Krieg, 2002) that are unmethylated at cytosine residues. This is in contrast to eukaryotic nuclear DNA, which is typically methylated at cytosine residues and has signi¢cantly fewer CpG dinucleotides compared with the bacterial genome (Bird, 1987) . These di¡erences in structure and content render eukaryotic nuclear DNA nonstimulatory. Synthetic ogliodeoxynucleotides have been used to study the in vitro e¡ects of DNA on di¡erent immune cell populations, and modi¢cations such as the incorporation of nuclease-resistant backbone structures, have been shown to amplify dramatically the immunostimulatory properties (Krieg et al, 1995) . Inversion of the dinucleotide CpG to GpC, or alterations to the £anking sequences abrogate the immunostimulatory e¡ect. Phosphorothioate ogliodeoxynucleotides are more resistant to degradation by nucleases compared with phosphodiester-containing ogliodeoxynucleotides, and are powerful activators of macrophages, dendritic cells, neutrophils, and B cells. Some researchers suggest that bacterial DNA should be regarded as one of the pathogen-associated molecular patterns, together with lipopolysaccharide and lipoteichoic acid (reviewed by Hacker et al, 2002) . Immunostimulatory ogliodeoxynucleotides are optimally 20 nucleotides in length and the £anking regions are also of importance for the stimulatory e¡ects. Speci¢c nucleotide sequences have been shown to have optimal immunostimulatory activities for di¡erent species (Van Uden and Raz, 2000) . For example, the optimal sequence for the activation of murine cells is GACGTT, and the optimal sequence for the activation of human cells is GTCGTT. Ogliodeoxynucleotides activation of immune cells can be used for its bene¢cial e¡ects, e.g., as adjuvants in vaccination; however, adverse in£ammatory e¡ects that follow the administration of ogliodeoxynucleotides comprise both local and systemic reactions, including arthritis (Deng et al, 1999) , meningitis (Deng et al, 2001) , and life-threatening symptoms of septic shock (Sparwasser et al, 1997) . The aim of this study was to assess the in£ammatogenic potential of bacterial DNA and synthetic ogliodeoxynucleotides in the skin. The elucidation of DNA-induced pathways of in£ammation is particularly relevant to dermatology since (1) bacterial infections frequently occur in the skin, and (2) synthetic oligonucleotides are frequently administered intracutaneously or subcutaneously, as part of a vaccination regimen.
MATERIALS AND METHODS
Mice Female, 8 wk old NMRI mice and female 7 to 8 wk old BALB/C mice were purchased from B&K Universal (Sollentuna, Sweden). Female SCID mice and sex-matched congeneic CB17 control mice were purchased from M&B (Bomholtvej, Denmark). The mice were housed at the animal facility of the Department of Rheumatology and In£ammation Research, University of G˛teborg and maintained under standard conditions of temperature and light, and fed laboratory chow and water ad libitum.
Oligonucleotides The nuclease-resistant, phosphorothioate^backbone ogliodeoxynucleotides and the phosphodiester-backbone ogliodeoxynucleotides that were used in this study are listed in Table I . All of the ogliodeoxynucleotides were synthesized by Scandinavian Gene Synthesis AB (K˛ping, Sweden), and shown to contain less than 5 fg of endotoxin per mg DNA, as assessed by the Limulus amoebocyte lysate assay. Genomic DNA was puri¢ed from Staphylococcus aureus strain LS-1 as described previously (Deng et al, 1999) and resuspended in phosphate-bu¡ered saline (PBS). The DNA sample originating from S. aureus was shown to contain 0.04 pg of endotoxin per mg DNA (Limulus amoebocyte lysate assay, Charles River, Charleston). Nuclear DNA was extracted from nuclei isolated from NMRI mouse livers essentially as described by Wang (1967) . Ten micrograms of the respective ogliodeoxynucleotide were injected intradermally on the shaved back of the mice. The oligonucleotides were diluted in PBS, and inoculated in a volume of 50 mL.
Histopathologic examination After routine procedures, tissue sections from skin samples corresponding to the injection sites were cut and stained with hematoxylin and eosin. All slides were coded and assessed in a blinded manner. The specimens were evaluated with regard to the extent of the in£ammation and judged on an arbitrary scale, from grade 0 (no signs of in£ammation), grade 1 (mild di¡use or focal in£ammation in a single area), to grade 2 (moderate di¡use or focal in£ammation), and grade 3 (heavy di¡use and focal in£ammation). Examples of typical grade 0, 1, 2, and 3 reactions are presented in Fig 1 .
Skin samples were also analyzed regarding the occurrence of CD11b þ cells encompassing macrophages and neutrophils (macrophages expressing a single rounded nucleus and neutrophils displaying multilobular nucleus) and CD3 -expressing T cells. Brie£y, skin samples were frozen in isopentane prechilled with liquid nitrogen, and kept . In (a) 10 mg of phosphorothioate-GpC was injected, in (b^d) 10 mg of phosphorothioate-CpG was injected. All samples were collected at day 7 after injection.
at À701C until cryosectioned. All of the sections were ¢xed in cold acetone for 5 min and washed in PBS. The sections were incubated overnight in a humid atmosphere at þ 41C with unlabeled rat anti-CD11b (Mac-1; M1/70) (Springer et al, 1979) or rat anti-CD3 (clone 17A2 PharMingen, San Diego, California) monoclonal antibodies (MoAb), which were diluted in PBS containing 1% bovine serum albumin. After several washes, endogenous peroxidase was depleted by treatment with 0.3% H 2 O 2 for 5 min biotin-labeled rabbit anti-rat immunoglobulin (Vector Laboratories, Burlingame, California) diluted in PBS/bovine serum albumin were used as secondary anti-bodies. The binding of biotin-labeled secondary antibodies was detected by stepwise incubation with streptavidin^biotin complex/horseradish peroxidase (DAKO, Glostrup, Denmark) and 3 -amino-9-ethyl-carbazole containing H 2 O 2 . All sections were counterstained with Meyer's hematoxylin.
Monocyte/macrophage depletion Etoposide (Bristol-Myers Squibb AB, Bromma, Sweden) is a cytotoxic drug that is known to deplete selectively the monocyte/macrophage populations in rabbits and mice ( Van't Wout et al, 1989) . Etoposide acts by inhibiting the function of DNA topoisomerase II, and thus interrupts the late S/G 2 phase of the cell cycle (Smith et al, 1994) . Etoposide was diluted 1:10 in PBS (0.13 M NaCl, 10 mM sodium phosphate (pH 7.4)) from a stock solution of 20 mg per mL. A volume of 120 mL, which corresponded to 12.5 mg per kg body weight of etoposide, was injected subcutaneously (s.c.) in BALB/C mice on 2 consecutive days before, and on 5 consecutive days after, intradermal injection of the phosphorothioate ogliodeoxynucleotide. The dose of etoposide was chosen according to that established in earlier studies (Calame et al, 1994) . Fluorescence-activated cell sorter analysis of peripheral blood was performed to assess the e¡ect of macrophage depletion, as previously described in detail , and showed that etoposide depleted the monocyte population by 80%. Control BALB/C mice received the same volume of PBS intraperitoneally (n ¼ 5) or subcutaneously (n ¼ 5).
Neutrophil depletion MoAb RB6 -8C5 is a rat immunoglobulin G2b (IgG2b) antibody that selectively binds to and depletes mature mouse neutrophils and eosinophils in BALB/C but not NMRI strain of mice. Hybridoma cells secreting RB6 -8C5 were a kind gift from R. Co¡man (DNAX Research Institute, Palo Alto, California). The hybridoma cells were expanded in Iscove's medium (Gibco, Paisley, UK) supplemented with 5% heat-inactivated fetal bovine serum (Seralab, Crawley Down, UK), 50 mg gentamicin per mL, 2 mM L-glutamine, and 5 Â10^5 M b-mercaptoethanol. The cells were grown to maximum density and the immunoglobulins were precipitated with 50% saturated ammonium sulfate, dialyzed against PBS, and ¢lter sterilized. The concentrations of immunoglobulins were determined by the radial immunodi¡usion method (Mancini et al, 1965) . As a control, monoclonal immunoglobulinclass-matched anti-ovalbumin antibodies (anti-OVA MoAb) were used (kindly provided by Dr Telemo, Department of Rheumatology and In£ammation Research, University of G˛teborg, Sweden). Analysis of peripheral blood by £uorescence-activated cell sorter has previously shown depletion of the granulocyte population by more than 90% within 48 h Molne et al, 2000) . BALB/C mice were injected intraperitoneally with one mg of either the MoAb RB6 -8C5 or the class-matched anti-OVA MoAb 2 h before, and 2 and 5 d after intracutaneous injection of the CpG-ogliodeoxynucleotide.
Interleukin (IL)-6 analysis Serum IL-6 levels was assessed to measure a possible systemic e¡ect of the oligonucleotide administered. The cell line B13.29, which is dependent on IL-6 for growth, has been described previously (Lansdorp et al, 1986; Aarden et al, 1987; Helle et al, 1988) . For IL-6 determinations, the more sensitive subclone B9 was used. B9 cells were harvested from tissue culture £asks, seeded on to microtiter plates (Nunc, Roskilde, Denmark) at a concentration of 5000 cells per well, and cultured in Iscove's medium supplemented with 5 Â10 À5 M 2-mercaptoethanol, 10% fetal bovine serum gentamycin (50 mg per mL), and L-glutamine. The serum samples were added for 68 h and [ 3 H]thymidine was added 4 h prior to harvesting. Each sample was tested for IL-6 in a series of 2-fold dilutions and compared with a recombinant IL-6 standard. B9 cells do not react with recombinant cytokines, such as IL-1a, IL-1b, IL-2, IL-3, IL-5, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-a, and interferon-g and have only weak reactivity with IL-4 (Helle et al, 1988) .
Experimental protocol NMRI mice were injected intradermally with either phosphorothioate CpG-ogliodeoxynucleotide or GpC-ogliodeoxynucleotide and serum samples were taken for analysis of IL-6 levels at days 0, 2, 7, and 21. Skin samples for histopathologic analysis of the size and density of the in£ammatory in¢ltrate were obtained at days 2, 7, and 21. NMRI mice were also injected with phosphodiester CpG-ogliodeoxynucleotide or GpC-ogliodeoxynucleotide as well as DNA from S. aureus LS-1 strain. Skin samples were obtained for histopathologic analysis on days 2 and 7 postinoculation. SCID mice and their controls (CB17) were injected intradermally with phosphorothioate CpG-ogliodeoxynucleotide and skin samples for histopathologic analysis were obtained at day 7. The BALB/C mice were injected with phosphorothioate CpGogliodeoxynucleotide and with etoposide, RB6 -8C5, control MoAb, or PBS, respectively. Skin samples for histopathologic analysis were obtained 7 d after injection of the ogliodeoxynucleotide.
Statistical analysis
The di¡erences between mean values were tested for statistical signi¢cance using the nonparametric Mann^Whitney U test. pr0.05 was considered to be statistically signi¢cant.
Ethics This study was approved by the local ethics committee for animal use (registration number 175^2000) at Go º teborg University.
RESULTS
Nuclease-resistant, phosphorothioate-modi¢ed CpG oligonucleotide (oligonucleotide 1600) induced in£ammation in the skin of NMRI mice at doses of 50 mg as well as 10 mg. As no major di¡erences were observed in either the size or density of the in£ammatory in¢ltrate, a dose of 10 mg of oligonucleotide was used consistently throughout this study. An in£ammatory in¢ltrate equal to grade 2 or 3 frequently included all layers of the skin and often engaged not only subcutaneous fat and dermis, but also the super¢cial muscle. The in£ammatory in¢ltrate consisted mainly of macrophages, whereas neutrophils were less frequent. Lymphocytes occurred sparsely in all the skin biopsies. These ¢ndings were con¢rmed with immunohistochemistry.
In£ammatogenic properties of phosphodiester^ogliodeoxy-nucleotide and phosphorothioate-ogliodeoxynucleotide in murine skin Nuclease-sensitive, phosphodiester CpG-oligonucleotide (oligonucleotide 0899) triggered in£ammatory changes in NMRI mice with peak values 2 d after injection and almost complete resolution 7 d after injection (Fig 2) . The Figure 2 . In£ammatory responses triggered by bacterial DNA and phosphodiester oligonucleotides. Nuclease-sensitive bacterial DNA from S. aureus LS-1 triggers heavy in£ammatory changes in skin within 2 d following injection, whereas the GpC-ogliodeoxynucleotide is inert. On day 7 the in£ammatory responses have resolved partially, with absence of in£ammation in mice injected with PBS or GpC-ogliodeoxynucleotide, but with still noticeable in£ammation in mice injected with bacterial DNA and CpG-ogliodeoxynucleotide (n ¼ 9^10 in all groups) ( nn po0.01; n po0.05).
injection of bacterial DNA (S. aureus LS-1) in NMRI mice displayed the same pattern of in£ammation, with peak values 2 d after injection (Fig 2) . Furthermore, the in£ammation was more pronounced in the bacterial-DNA injection group. In contrast, injection of phosphodiester GpC-oligonucleotide (oligonucleotide, 1800) did not trigger in£ammation (Fig 2) . Methylated phosphodiester CpG-ogliodeoxynucleotide (ogliodeoxynucleotide 2798) did not induce any in£ammation in seven of nine NMRI mice, and slight (grade 1) in£ammation in two of nine mice 7 d after injection. Nuclease-resistant, phosphorothioate-modi¢ed CpG-oligonucleotide induced in£ammatory changes in NMRI mice that peaked at day 7, with almost total resolution at day 21 (Fig 3) . The few remaining in£ammatory cells present on day 21 were mostly of monocyte/macrophage origin.
For the control purpose, we have also assessed the impact of homologous DNA (mouse liver DNA) on the induction of skin in£ammation. Our results show clearly that NMRI mice injected intracutaneously with 10 mg of highly puri¢ed nuclear mouse liver DNA will not rise any in£ammatory response (day 2: one of 10 mice displayed grade 1 in£ammation; day 7: none of 10 mice displayed in£ammation).
E¡ects of depletion of immune cell populations on oligonucleotide-induced skin in£ammation The presence of macrophages has been shown to be mandatory for the development of arthritis following intra-articular injection of CpG-oligonucleotide, whereas neutrophils, natural killer cells, T cells, and B cells played minor parts in this type of in£ammation . We investigated whether this pattern was also valid for DNA-triggered in£ammation of the skin. BALB/C mice were injected intradermally with 10 mg of CpGogliodeoxynucleotide (ogliodeoxynucleotide 1600) and administered with (1) the macrophage-depleting drug etoposide (n ¼ 10), or (2) the anti-granulocytic antibody RB6 -8C5 (n ¼ 19), or (3) PBS or immunoglobulin class-matched IgG antibodies speci¢c for ovalbumin (n ¼ 21). SCID mice (n ¼ 9), which lack both T and B cells and their congeneic (CB17) controls (n ¼ 9) were also injected with 10 mg of CpG-ogliodeoxynucleotide (ogliodeoxynucleotide 1600). All of the mice were killed 7 d after injection and skin samples were obtained for histopathologic examination and grading (see Materials and Methods section). Depletion of monocytes/macrophages with etoposide resulted in a signi¢cant reduction in the severity of in£ammation in the skin (p ¼ 0.0001). A statistically signi¢cant (p ¼ 0.0001) decrease in the in£ammatory in¢ltrates was seen also in mice that were treated with anti-granulocytic antibodies (Fig 4) . Also, signi¢cant di¡erences of low degree (po0.05) were seen in the severity of the in£ammatory in¢ltrate in SCID mice compared with controls (Fig 4) . Serum IL-6 levels Serum levels of IL-6 have been shown to increase transiently after intra-articular injection of CpGogliodeoxynucleotide . Intracutaneous injection of DNA led to a slight, but not statistically signi¢cant, increase in serum levels of IL-6 2 d after intradermal injection of 10 mg of phosphorothioate CpG-ogliodeoxynucleotide (58710 pg per mL on day 0 vs 163752 pg per mL on day 2 (mean7SEM); p ¼ 0.06). There were no statistically signi¢cant di¡erences in serum IL-6 levels in these groups compared with groups of mice injected with the same dose of GpC-ogliodeoxynucleotide (data not shown).
DISCUSSION
The skin is frequently exposed to both bacterial DNA, e.g., during cutaneous infections such as erysipelas and impetigo, and to synthetic phosphorothioate oligonucleotide, as in adjuvants and various vaccination regimens. We have previously shown that Figure 3 . Phosphorothioate CpG-ogliodeoxynucleotide but not GpC-oligonucleotide triggers cutaneous in£ammation. Signi¢cant local skin in£ammation is evident following intradermal injection of 10 mg of phosphorothioate CpG-ogliodeoxynucleotide compared with 10 mg of phosphorothioate GpC-ogliodeoxynucleotide. Pooled data from three di¡erent experiments are shown (n ¼ 8^10, day 2; n ¼ 18^19, day 7; and n ¼ 7^9, day 21) ( n po0.05; nnn po0.001; n.s., not statistically signi¢cant). (CB17) were injected intradermally with 10 mg of phosphorothioate CpG-ogliodeoxynucleotide. Depletion of monocytes/ macrophages (n ¼ 10) by etoposide as well as depletion of neutrophils (n ¼ 19) by anti-neutrophilic antibody RB6 -8C5 resulted in a signi¢cant decrease of the severity of the in£ammation ( nnn po0.0001), compared with BALB/C mice injected with CpG and relevant control (OVA MoAb; n ¼ 10 or PBS; n ¼ 11). Results from both control groups are pooled, as no di¡er-ences were seen between the groups. Also, the ogliodeoxynucleotide-induced in£ammatory in¢ltrates in SCID mice (n ¼ 9) and their controls (CB17) (n ¼ 9) were signi¢cantly di¡erent after injection with the same dose (10 mg) of CpG-ogliodeoxynucleotide ( n po0.05). All samples are collected at day 7 following injection with CpG-ogliodeoxynucleotide.
bacterial DNA, in contrast to eukaryotic nuclear DNA, exerts in£ammatory e¡ects in joints (Deng et al, 1999) and in the central nervous system (Deng et al, 2001) . Similar ¢ndings have also been reported by others (Schluesener et al, 2001; Takeshita et al, 2001; Zeuner et al, 2002) . The immunostimulatory e¡ects of bacteriallike CpG oligonucleotides require DNA uptake and endosomal acidi¢cation (reviewed in Krieg, 1999) , and are mediated through Toll-like receptor 9, which recognizes a speci¢c pattern in the bacterial DNA (Hemmi et al, 2000) . As the skin is commonly the site of bacterial infections and almost exclusively the site of vaccination procedures, we felt that the question related to in£ammatogenicity of prokaryotic DNA sequences in this compartment should be addressed. Our results indicate both similarities and di¡erences between bacterial DNA in£ammato-genicity in the skin as compared with the joints.
In accordance with previous results, (Deng et al, 1999) monocytes/macrophages played a central part in mediating skin in£am-mation following intracutaneous injection of bacterial DNA. Indeed, both histologic stainings and immunohistochemistry of skin samples showed a plethora of macrophages that had in¢l-trated all layers of the skin. In addition, pretreatment of mice with a topoisomerase II inhibitor (etoposide), which leads to selective apoptosis of monocytic cells, resulted in signi¢cant downregulation of the in£ammatory response of skin to DNA. Thus, this cell population and its soluble products (e.g., cytokines, chemokines, nitric oxide) are crucial to the observed in£ammatory response to DNA. This ¢nding is corroborated by the recent study of von Stebut et al (2002) , where stimulation of skinderived macrophages with CpG-ogliodeoxynucleotide resulted in induction of IL-12, interferon-g, and nitric oxide resulting in killing of Leishmania parasites. Interestingly, and in contrast to previous ¢ndings in DNA-injected joints, neutrophils also participated in DNA-triggered skin in£ammation. Indeed, depletion of this cell population with a speci¢c MoAb led to a signi¢cant downregulation of the in£ammatory responses in skin. It should be pointed out that in order to assess the signi¢cance of neutrophils with regard to bacterial DNA-triggered skin in£ammation we needed to use another strain of mice (BALB/C), known to be sensitive to the depletion procedure. Recent work from our laboratory (Bylund et al, 2002) showed that phosphorothioate CpG-oligonucleotide activation of neutrophils led to respiratory burst and degranulation of both speci¢c and gelatinase granules.
In contrast to the active roles of monocytes/macrophages and neutrophils in bacterial DNA-triggered skin in£ammation, it is clear that the acquired immune system does not as vividly participate in this process. SCID mice, which lack functional T/B lymphocytes, showed somewhat less severe in£ammation compared with those of the congeneic CB17 strain. Most probably, this ¢nd-ing is due to the lack of B cells, known to be activated by bacterial DNA (Yi et al, 1998) . In this study, we showed that both phosphodiester-backbone DNA and phosphorothioate-backbone DNA were able to trigger skin in£ammation; however, the phosphodiester-oligonucleotide, as well as staphylococcal DNA-triggered in£ammatory responses were less durable compared with those induced by synthetically modi¢ed phosphorothioate-backbone oligonucleotides.
What is the biological signi¢cance of our ¢ndings? It has been suggested that local intradermal injection of CpG ogliodeoxynucleotide triggers an early host response to a simulated bacterial invasion, as indicated by increased migration of Langerhans cells from the epidermis (Ban et al, 2000) . Di¡erent routes of administration of CpG-ogliodeoxynucleotide may lead to di¡erential activation patterns of immune cells, e.g., predominantly polymorphonuclear granulocytes in the case of in£ammation in the lower respiratory tract (Schwartz et al, 1997) . Systemic, rather than local administration of CpG-ogliodeoxynucleotide, led to downmodulation of in£ammation in an experimental model of asthma (Kline et al, 1998) . The potential of immunostimulatory DNA sequences to trigger a T helper 1-polarized response is well documented and might be bene¢cial in chronic skin diseases that have T helper 2-type immune reactivity, such as pemphigus, pemphigoid, and cutaneous lupus erythematosus. Altogether our results indicate that both bacterial DNA and synthetic ogliodeoxynucleotide trigger local skin in£ammation. Limited, local in£ammation of this type might be advantageous for the host in allowing it to mobilize an e⁄cient protective response. Under certain circumstances, however, this might induce or aggravate chronic skin in£ammatory diseases, such as eczema and psoriasis.
